secukinumab,adalimumab
novartis,abbvie
['adalimumab', 'axspa', 'secukinumab']
is there a difference between il-17i and tnfi in preventing radiographic progression in radiographic axspa?
head to head study secukinumab vs. adalimumab biosimilar shows no sig difference with low radiographic progression. #acrbest abs#l15 #acr22 
Rheumatologist. Amateur chef. YNWA. Views and opinions are my own.